Skip to main content
Clinical Trials/NCT04737083
NCT04737083
Unknown
Not Applicable

Evaluation of CGH Array in Prenatal Diagnosis of Bilateral Clubfoot

Central Hospital, Nancy, France0 sites50 target enrollmentJanuary 31, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Clubfoot
Sponsor
Central Hospital, Nancy, France
Enrollment
50
Primary Endpoint
rate of abnormal CGH-array in the population
Last Updated
5 years ago

Overview

Brief Summary

In prenatal diagnosis of isolated bilateral clubfoot our team propose genetic analysis: a CGH-array. We want to study the rate of aberrations in these cases.

Registry
clinicaltrials.gov
Start Date
January 31, 2021
End Date
November 30, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Central Hospital, Nancy, France
Responsible Party
Principal Investigator
Principal Investigator

Matthieu DAP

medical doctor (MD)

Central Hospital, Nancy, France

Eligibility Criteria

Inclusion Criteria

  • pregnant women
  • fetus with isolated bilateral clubfoot

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

rate of abnormal CGH-array in the population

Time Frame: 9 months

Secondary Outcomes

  • type of abnormalities in CGH-array study(9 months)

Similar Trials